# Examining the Effect of Mental Health Disorders on Vascular Function and Exercise Tolerance

> **NCT03216980** · NA · COMPLETED · sponsor: **Virginia Commonwealth University** · enrollment: 40 (actual)

## Conditions studied

- Mental Health Disorders

## Interventions

- **DIETARY_SUPPLEMENT:** PTSD/GAD Antioxidant
- **DIETARY_SUPPLEMENT:** PTSD/GAD Placebo
- **DIETARY_SUPPLEMENT:** Healthy Control Antioxidant
- **DIETARY_SUPPLEMENT:** Healthy Control Placebo

## Key facts

- **NCT ID:** NCT03216980
- **Lead sponsor:** Virginia Commonwealth University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-15
- **Primary completion:** 2021-03-31
- **Final completion:** 2021-03-31
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2021-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03216980

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03216980, "Examining the Effect of Mental Health Disorders on Vascular Function and Exercise Tolerance". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03216980. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
